Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab.
Alyssa A TooropZoë Y G J van LieropEva M M StrijbisCharlotte E TeunissenAxel PetzoldMike P WattjesFrederik BarkhofBrigit A de JongZoé Léonie Elise van KempenJoep KillesteinPublished in: Neurology(R) neuroimmunology & neuroinflammation (2020)
The clinical course of carryover PML was mild in both patients, suggesting that B-cell depletion possibly did not aggravate PML-IRIS in these 2 patients.